knowledge -WSS

knowledge

author：leisure time 2025-09-03 05:28:50 - browse：12

Researchers say they’ve been able to measure recovery from treatment-resistant depression through brain scans — a crucial step toward quantifying the impact of therapies on a condition whose progress is notoriously difficult to measure objectively. And that’s thanks to generative AI, they say.

In a small study published Wednesday — just 10 people with severe, treatment-resistant depression receiving deep brain stimulation therapy — researchers used the electrodes to record brain activity and later fed the scans into a homegrown artificial intelligence system that analyzed them for patterns. They found that it was possible to track patients’ recovery through changes in brain cells’ electrical activity.

Finding so-called biomarkers, or objective measurements reflecting depression, could help diagnose depression, track its progression, predict a relapse, and better tailor therapies to individual patients. But finding those metrics has been difficult, partly because depression’s biological impact isn’t well understood.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Twill hunts for pharma partner to market its depression app

focus

knowledge

WSS

Medicare drug price negotiation’s day in court

More hospitals are billing patients as online messages surge

Commercial surrogacy can be ethical, despite pope’s claims

Congressmen charge Covid hearing ‘could have been an email’

Juul spent big to court Black leaders to promote its e

Even great ERs can’t make up for American health disparities

focus

knowledge

focus

Trump demands the U.S. pay no more for drugs than other countries … again

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Heart attack and stroke risk calculators need revising

FDA seeking to stop procedures at two unregulated stem cell clinics

Sports medicine is finally prioritizing gender equality

Apple Vision Pro: A first look at health apps on the new VR headset

BioMarin wins approval for gene therapy to treat hemophilia A

Do digital therapeutics have a future in medicine?

Psychedelics group wrestles with new pharma identity

New Ultima Genomics DNA sequencer can read genome for $100

Wikipedia

Vertex non

A $475,000 price tag for a new cancer drug: crazy or meh?

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

What we know about the American soldier detained in North Korea

Robert Kennedy Jr.'s presidential campaign attracts GOP

Congressmen charge Covid hearing ‘could have been an email’

hotspot

focus

knowledge

leisure time